🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
The GI-4000 therapeutic vaccine or placebo will be injected under the skin ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-01
Trial ID
NCT00300950
Treatments Being Tested
This multicentre, randomized controlled trial evaluates the effect and safe...
Status
Recruiting
Location
Guangdong Provincial Hospital of Chinese Medicine
Start Date
2026-01-15
Trial ID
NCT07337096
Treatments Being Tested
The primary scientific question of interest of this study is whether the co...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT05809895
Treatments Being Tested
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This study will evaluate the efficacy and safety of atezolizumab plus chemo...
Status
Completed
Location
Florida Cancer Specialists - Fort Myers (Broadway)
Start Date
2018-01-11
Trial ID
NCT03371017
Treatments Being Tested
GSK1120212 is a potent and highly selective inhibitor of MEK phosphorylatio...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08
Trial ID
NCT01231581
Treatments Being Tested
This research study will investigate the safety and effectiveness of two di...
Status
Completed
Location
University of Southern Alabama Mitchell Cancer Institute
Start Date
2008-10
Trial ID
NCT00771810
The objective is to compare efficacy and safety of masitinib in combination...
Status
Completed
Location
Hospital AZ Sint-Jan
Start Date
2014-07
Trial ID
NCT03766295
Treatments Being Tested
Cholangiocarcinoma (CCA) is a heterogeneous group of cancers arising from t...
Status
Recruiting
Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2023-09-01
Trial ID
NCT05823311
Treatments Being Tested